Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists

Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists

US Patent 10240210 · Granted Mar 26, 2019

Estimated economic value: $4,610,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy for cancer using bromodomain and extra-terminal (BET) protei2022
Methods of stratifying patients for treatment with retinoic acid receptor-alpha 2022
Methods of stratifying patients for treatment with retinoic acid receptor-alpha 2022
Methods of stratifying patients for treatment with retinoic acid receptor-α agon2021
Methods of stratifying patients for treatment with retinoic acid receptor-α agon2021
Methods of stratifying patients for treatment with retinoic acid receptor-α agon2021
Methods of stratifying patients for treatment with retinoic acid receptor-α agon2021
Methods of stratifying patients for treatment with retinoic acid receptor-α agon2021
Uses of diazepane derivatives2020
Methods of stratifying patients for treatment with retinoic acid receptor-alpha 2020
Methods of stratifying patients for treatment with retinoic acid receptor-alpha 2020
Methods of stratifying patients for treatment with retinoic acid receptor-alpha 2019